Chicago / Edinburgh
IPOX® Schuster LLC
NOT JUST ANOTHER INDEX. IT'S THE NEW GENERATION®

Think IPO. Think IPOX®.

Specialized solutions for investors seeking exposure to the companies shaping what comes next.

Discover our indexesMeet IPOX®
THE IPOX® INDEXES
Other indexes
IPOX® SCHUSTERINDEXES · RESEARCH · NEW LISTINGSEST. 2004
THE GLOBAL PIPELINE

Upcoming listings

Explore the calendar +

15 upcoming listings

RESEARCH & INSIGHT

Our newsletters

All newsletters +
LATEST FROM IPOX®

News

All news +
Reuters: IPOX® VP Kat Liu Comments on Iambic Therapeutics’ AI Drug Discovery Platform and IPO Valuation
Media mentions · Reuters

Reuters: IPOX® VP Kat Liu Comments on Iambic Therapeutics’ AI Drug Discovery Platform and IPO Valuation

Nvidia-backed Iambic Therapeutics is seeking to raise up to $159.4 million in its U.S. IPO, targeting a valuation of up to $805.8 million. IPOX® Vice President Kat Liu told Reuters that Iambic’s value depends primarily on its drug pipeline and prospects for approval and commercialization. The company uses AI to develop cancer treatments and plans to list on Nasdaq as “IAM,” as biotech attracts investor interest despite rising Treasury yields, market volatility, and geopolitical tensions affecting the broader IPO market.

October 9, 2026Kat Liu
Fortune: IPOX® VP Kat Liu Comments on Oura’s Postponed IPO and Valuation Questions
Media mentions · Fortune

Fortune: IPOX® VP Kat Liu Comments on Oura’s Postponed IPO and Valuation Questions

IPOX® VP Kat Liu was interviewed for Fortune on Oura’s decision to postpone its IPO, offering perspective on valuation concerns, deal structure, and investor expectations. Liu discussed how Oura’s positioning as either a digital-health platform or consumer hardware company could shape valuation views, while also noting the market signal created by a high proportion of secondary shares.

October 6, 2026Kat Liu
Reuters: IPOX® Associate Lukas Muehlbauer Comments on Airtel Money’s London IPO
Media mentions · Reuters

Reuters: IPOX® Associate Lukas Muehlbauer Comments on Airtel Money’s London IPO

Reuters reports that Airtel Money is targeting a valuation of approximately $7 billion in its London IPO, which could become the city’s largest offering since September 2025. IPOX® Associate Lukas Muehlbauer said the deal demonstrates London’s ability to attract sizable international listings while also reflecting a buyer’s market. He noted that companies must remain realistic about valuation as Airtel Money prepares to raise about $703 million through the sale of 270 million shares ahead of its October debut.

October 1, 2026Lukas Muehlbauer
Reuters: IPOX® Associate Lukas Muehlbauer Comments on Oura IPO Delay and Market Conditions
Media mentions · Reuters

Reuters: IPOX® Associate Lukas Muehlbauer Comments on Oura IPO Delay and Market Conditions

Reuters reports that Oura postponed its planned U.S. IPO as market volatility and higher interest rates increased investor caution toward new listings. IPOX® Associate Lukas Muehlbauer commented that higher rates are making investors more selective, particularly on growth valuations, while noting that the IPO window remains open. He also highlighted reported demand for Oura’s offering, which was said to be around four times oversubscribed, and pointed to Anthropic’s planned IPO as an important upcoming market test.

October 1, 2026Lukas Muehlbauer
Reuters: IPOX® VP Kat Liu Discusses Investor Selectivity in Accelevation’s AI Infrastructure IPO
Media mentions · Reuters

Reuters: IPOX® VP Kat Liu Discusses Investor Selectivity in Accelevation’s AI Infrastructure IPO

Reuters reports that Accelevation is targeting a valuation of up to $5.37 billion in its U.S. IPO, seeking to raise up to $720 million. IPOX® Vice President Kat Liu said investors are becoming more selective as AI infrastructure offerings expand, focusing on companies’ value-chain positioning, backlog quality, and ability to convert demand into revenue, margins, and cash flow. Accelevation provides power distribution, cooling, and modular infrastructure for data centers supporting growing AI computing demand.

September 25, 2026Kat Liu
Barron's: IPOX® Founder Josef Schuster Comments on Retail Access to IPO Allocations
Media mentions · Barron's

Barron's: IPOX® Founder Josef Schuster Comments on Retail Access to IPO Allocations

IPOX® CEO Josef Schuster commented in Barron's on how growing retail access to IPO allocations through platforms such as Robinhood, SoFi and Coinbase could influence short-term trading in newly listed companies. Discussing Oura’s upcoming IPO, Schuster noted that restrictions on future IPO access may discourage investors from quickly selling allocated shares, potentially affecting early trading dynamics. The article also highlighted IPOX®’s broader role in IPO market research and its index tracked by the First Trust US Equity Opportunities ETF.

September 25, 2026Josef Schuster
View archive
OUR SERVICE OFFERINGS

A world of new listings.
A disciplined approach.

New listings reflect economic growth and innovation. Our services bring a disciplined approach to this evolving global universe through independent research, index licensing, portfolio management and tailored investment solutions.

Explore our services
THE IPOX® NEWSLETTERS

Stay ahead of the next listing.

Research and insight from the global new listings market.

Explore our newsletters